News Sentiment

SNN sentiment intelligence

Smith & Nephew SNATS Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 58 Balanced news tone 62 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 30.70 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+1.5% over one week, +0.4% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Smith & Nephew stock trades steadily as recent earnings highlight margin focus

Market Reaction

Balanced read

66/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction 1.5% Price digesting
Trend fit Trend inactive 0.4% over four weeks
Fair value 9.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 24
Neutral 36
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 10
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
TradingView 8
ad-hoc-news.de 7
Stock Titan 5
GuruFocus 4
AD HOC NEWS 4
simplywall.st 4
Ad Hoc News 3

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 17
Analyst action 5
Capital return 4
Guidance 3
Balance sheet 2
Deals and strategy 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 62
Stock Titan Direct company coverage

Cevian Capital lifts Smith & Nephew (SNN) voting stake to 13.206621% via TR-1

Cevian Capital has increased its voting stake in Smith & Nephew (SNN) to 13.206621%, up from 13.056468%, through an investor group linked to Cevian Capital II GP Limited. This represents 111,788,454 voting rights, all directly attached to shares, with holdings split between Cevia

Tone
Neutral 50/100
Event
Deals and strategy
Published
30 Jun 2026 10:41
Source
Stock Titan
The Globe and Mail Direct company coverage

RBC Capital Sticks to Their Hold Rating for Smith & Nephew (SN)

RBC Capital analyst Charles Weston maintained a Hold rating on Smith & Nephew (SN) with a price target of p1,350.00. This follows previous Hold ratings from Barclays and a Buy rating from Goldman Sachs. Smith & Nephew reported quarterly revenue of p3.31 billion and a net profit o

Tone
Neutral 50/100
Event
Analyst action
Published
30 Jun 2026 09:09
Source
The Globe and Mail
TradingView Direct company coverage

REG - Smith & Nephew Plc - Holding(s) in Company

Cevian Capital II GP Limited has increased its aggregate holding in Smith & Nephew Plc to 13.206621%, up from a previously notified 13.056468%. This change occurred on June 25, 2026, and was officially notified to the issuer on June 29, 2026. The increase is primarily due to an i

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 08:41
Source
TradingView
AD HOC NEWS Direct company coverage

REGENETEN bioinductive implant from Smith & Nephew plc - shoulder tendon repair with a quiet patch

The REGENETEN bioinductive implant from Smith & Nephew is a collagen-based patch designed to assist in shoulder rotator cuff repair by encouraging new tissue growth over damaged tendons. It is anchored arthroscopically and absorbed over time, reducing re-tear risk and providing a

Tone
Positive 71/100
Event
Market update
Published
30 Jun 2026 00:40
Source
AD HOC NEWS